Source disclosure: February 13, 2026
TAUNS Laboratories,Inc. [197A.T]
TOKYO, Feb 19 (Pulse News Wire) – Tauns Laboratories,Inc. (197A.T) reported consolidated results for Q2 FY2026 (ending June 2026).
28 billion (-30.9% YoY). 25 billion (-50.3%). net profit attributable to shareholders was ¥2.06 billion (-56.0%).
2 billion with an equity ratio of 39.4%. For the next fiscal year, the company forecasts 8 billion (+11.5%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/6 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥8,276M | -30.9% |
| Operating profit | ¥3,252M | -50.3% |
| Net profit | ¥2,060M | -56.0% |
Next period forecast
Revenue
¥20,769M
+11.5%Op. profit
¥8,323M
+0.7%Net profit
¥8,613M
+36.4%Source: TDNet filing · Figures in millions of yen